Yes, it was 2 days ago. The ASX investors are too dimwitted to interprate an announcement indicating FDA is prepared to work closely with Mesoblast to fast track their CHF treatment with even a shot at approval with no further trials for a blockbuster product whilst the SP sits at close to its 12 month lows.
MESO Nasdaq update, page-2556
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.015(1.28%) |
Mkt cap ! $1.307B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.21 | $1.14 | $4.759M | 4.065M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 55804 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 12902 | 3 |
View Market Depth
| Last trade - 11.21am 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.16 |
Change
-0.015 ( 1.47 %) |
||||
| Open | High | Low | Volume | ||
| $1.21 | $1.21 | $1.14 | 555161 | ||
| Last updated 11.39am 27/05/2024 ? | |||||
| MSB (ASX) Chart |